Get the Stockscreener App
0.6175
1.29%
-0.0081
Quoin Pharmaceuticals Ltd Adr stock is traded at $0.6175, with a volume of 16,183.
It is down -1.29% in the last 24 hours and down -28.58% over the past month.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
See More
Previous Close:
$0.6256
Open:
$0.606
24h Volume:
16,183
Relative Volume:
0.01
Market Cap:
$3.18M
Revenue:
-
Net Income/Loss:
$-8.28M
P/E Ratio:
-0.0134
EPS:
-45.9343
Net Cash Flow:
$-7.99M
1W Performance:
+1.73%
1M Performance:
-28.58%
6M Performance:
-17.68%
1Y Performance:
-85.44%
1-Day Range:
$0.606
$0.639
1-Week Range:
$0.5698
$0.68
52-Week Range:
$0.4772
$6.18
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Company Profile
Name
Quoin Pharmaceuticals Ltd Adr
Sector
Industry
Phone
97299741444
Address
23 HATA'AS STREET, KFAR SABA
Compare QNRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| QNRX | 0.625 | 3.18M | 0 | -8.28M | -7.99M | -45.93 |
| VRTX | 446.61 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 740.52 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 592.00 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 250.23 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 103.42 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Latest News
Quoin Pharmaceuticals advances Netherton syndrome treatment trial - Investing.com
Quoin Pharmaceuticals granted extension to meet Nasdaq listing - Investing.com India
Quoin Pharmaceuticals granted extension to meet Nasdaq listing By Investing.com - Investing.com UK
Quoin Pharmaceuticals expands UK clinical trials for rare disease - Investing.com
Quoin Pharmaceuticals sets date for 2024 shareholder meeting - Investing.com
Balance Sheet Insights: Quoin Pharmaceuticals Ltd ADR (QNRX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Quoin Pharmaceuticals CFO buys shares worth over $23,000 - Investing.com
Healthy Upside Potential: Quoin Pharmaceuticals Ltd ADR (QNRX) - SETE News
A closer look at QNRX’s price-to-free cash flow ratio - US Post News
Quoin Pharmaceuticals COO acquires $28,737 in company shares - Investing.com
Quoin Pharmaceuticals CEO acquires shares worth over $28k - Investing.com
Quoin Pharmaceuticals (NASDAQ:QNRX) Stock Quotes, Forecast and News Summary - Benzinga
QNRX Stock Hits 52-Week Low at $0.57 Amid Market Challenges - Investing.com Australia
Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference - GlobeNewswire Inc.
Quoin Pharmaceuticals partners with UCC for drug delivery tech By Investing.com - Investing.com
Quoin Pharmaceuticals director Dennis Langer sells shares worth $217 - Investing.com India
Quoin Pharmaceuticals director Dennis Langer sells shares worth $217 By Investing.com - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
GLMD Stock Quote Price and Forecast - CNN
U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.04% - Investing.com India
Major Indexes Muted Following Strong Jobs Report - Schaeffers Research
Quoin Pharmaceuticals (QNRX) Stock Price, News & Analysis - MarketBeat
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.42%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):